Combined inhibition of JAK/STAT pathway and lysine-specific demethylase 1 as a therapeutic strategy in CSF3R/CEBPA mutant acute myeloid leukemia.

Braun TP, Coblentz C, Smith BM, Coleman DJ, Schonrock Z, Carratt SA, Callahan RL, Maniaci B, Druker BJ, Maxson JE
Proc Natl Acad Sci U S A. 2020 Jun 16;117(24):13670-13679. doi: 10.1073/pnas.1918307117. Epub 2020 May 29. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.